CYP450 & Transporter Induction Testing

About Signatope

Signatope is a fast-growing, privately-held German biotech providing innovative proteomics services for the pharmaceutical and diagnostics sectors. Its proprietary platform, based on antibodies targeting minimal 4-amino-acid epitopes, allows for the development of highly specific, cross-species quantitative assays for challenging protein biomarkers, including isoforms and drug transporters. The company primarily serves drug development pipelines by offering critical tools for safety and toxicology biomarker assessment, positioning itself at the intersection of advanced proteomics and preclinical/clinical research support. Recent recognition, such as the Deloitte Technology Fast 50 Award, underscores its rapid growth and technological validation.

Therapeutic Areas